InvestorsHub Logo
Followers 3
Posts 582
Boards Moderated 0
Alias Born 01/19/2012

Re: None

Thursday, 09/13/2018 1:45:05 PM

Thursday, September 13, 2018 1:45:05 PM

Post# of 7730
I am confident to say the least. Reasons for affirmative CD if not Buyout (To my own surprise, I am now more inclined than ever to assume the latter:
1. Latest data of Imet concluded and available in May 2018, a discontinuation by JJ would have been confirmed weeks if not months ago.
2. Financially: Lack of inside sales of Geron employees, barring 1 automatic sale, despite epic run YTD is extremely bullish.
3. On Sept 4 JJ JJ placed imetelstat on their compassionate use list. With 5 months to review latest data, you can effectively conclude that JJ approves of Imet’s results otherwise this move would never have been made.
4. Finally, Imet’s involvement in JJ’s deck today, 3 slides: 5 Job posted .Strategic partnership, 15 as a potential filing, 24 PRODUCTS APPROVED/FILED OR PLANNED FILINGS 2017-2021. Again, if JJ was not interested in CD or full on acquisition, they would not include Imet in the presentation, period, let alone multiple times. It’s clear JJ is proud to be sponsoring this drugs

p.s. Job posted .
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GERN News